Your browser doesn't support javascript.
loading
Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.
Jaafari, Mahmoud Reza; Hatamipour, Mahdi; Alavizadeh, Seyedeh Hoda; Abbasi, Azam; Saberi, Zahra; Rafati, Sima; Taslimi, Yasaman; Mohammadi, Akram Miramin; Khamesipour, Ali.
Afiliação
  • Jaafari MR; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: jafarimr@mums.ac.ir.
  • Hatamipour M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Alavizadeh SH; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Abbasi A; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Saberi Z; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rafati S; Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
  • Taslimi Y; Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
  • Mohammadi AM; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
  • Khamesipour A; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: ali.khamesipour@gmail.com.
Int J Parasitol Drugs Drug Resist ; 11: 156-165, 2019 12.
Article em En | MEDLINE | ID: mdl-31582344

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anfotericina B / Leishmaniose Cutânea / Antiprotozoários Limite: Animals Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anfotericina B / Leishmaniose Cutânea / Antiprotozoários Limite: Animals Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2019 Tipo de documento: Article